Company intelligence / Profile preview

Biosearch Life

Ownership: Private
Development stage: Other

Overview

Biosearch Life is a leading biotechnology company specializing in the research, development and commercialization of natural bioactive ingredients—primarily standardized plant extracts (botanicals), lipids (notably Omega‑3 oils), and probiotics. Their products are used in functional foods/beverages, infant nutrition/formula, clinical nutrition/medical foods and dietary supplements. The company operates globally with a strong focus on innovation through proprietary ingredient platforms such as Hereditum®, Eupoly‑3®, and Exxentia®. In 2021 it was acquired by Kerry Group.

Therapeutic areas: Metabolic DisordersOther
Modalities: ProbioticsBotanical extractLipid
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Biosearch Life.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biosearch Life.

Explore the full profile